Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,635,841
+$41,439 QoQ
Shares Held
10,438
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#482
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 75%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SOMERVILLE KURT F holds $31,801,956 across 8 Drug Manufacturers - General names. NVS ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,877 | $14,952,986 | |
| 2 | LLY |
ELI LILLY & Co
|
9,217 | $11,055,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,539 | $1,996,761 | |
| 4 | NVS |
Novartis AG
This page
|
10,438 | $1,635,841 | |
| 5 | ABBV |
AbbVie Inc.
|
5,261 | $1,323,877 | |
| 6 | AMGN |
Amgen Inc
|
1,057 | $382,760 | |
| 7 | NVO |
Novo Nordisk A S
|
4,825 | $231,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,875 | $223,277 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,635,841 | 10,438 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,594,402 | 10,438 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,513,535 | 10,978 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,708,539 | 13,323 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,733,224 | 14,323 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,794,046 | 16,093 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,666,724 | 17,128 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,887,920 | 25,108 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,324,212 | 31,225 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,173,504 | 53,484 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,677,871 | 95,849 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,667,000 | 124,357 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,012,341 | 128,950 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,283,880 | 144,390 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,027,843 | 143,605 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $11,697,937 | 153,900 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $13,106,797 | 155,055 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $14,172,676 | 161,512 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $15,276,807 | 174,652 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $14,711,074 | 179,886 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $16,480,131 | 180,624 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $15,493,589 | 181,254 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,910,900 | 179,084 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $15,425,308 | 177,384 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $15,420,396 | 176,556 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $14,541,784 | 176,371 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||